Hunan Jingfeng Pharmaceutical Co.,Ltd.
Simbol: 000908.SZ
SHZ
2.07
CNYTržna cena danes
-6.8734
Razmerje P/E
-0.0686
Razmerje PEG
1.82B
Kapaciteta MRK
- 0.00%
Donos DIV
Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908-SZ) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 13.2 | 181.4 | 172.2 | |||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | -7.4 | |||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 85.9 | 233.2 | 301.3 | |||||||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 64.6 | 120.4 | 155.4 | |||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 14.9 | 36.4 | 48.7 | |||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 213.8 | 571.3 | 677.5 | |||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 434.2 | 566.4 | 726.1 | |||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0.1 | 33 | 33 | |||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 168.2 | 204.4 | 210.4 | |||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 168.3 | 237.4 | 243.5 | |||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 44.7 | 50.5 | 111.3 | |||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 10.4 | 27.9 | 23.6 | |||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 188.9 | 15 | 10.4 | |||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 846.6 | 897.2 | 1114.8 | |||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1060.3 | 1468.5 | 1792.3 | |||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 148.9 | 138.5 | 123 | |||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 498.9 | 516.5 | 864.6 | |||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 24.4 | 47 | 24.8 | |||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 95 | 82.4 | 8.9 | |||||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 20.7 | 24.8 | 51 | |||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 10.7 | 402.2 | 2.3 | |||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 172.5 | 170.3 | 103.5 | |||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 22.7 | 9.8 | 7.9 | |||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 1214 | 1253.6 | 1464.6 | |||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 112 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 416.7 | 416.7 | 416.7 | |||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1177.3 | -949 | -820.9 | |||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -18.6 | 710.3 | 710.6 | |||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 617.8 | 0 | 0 | |||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | -49.5 | 177.9 | 306.4 | |||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1060.3 | 1468.5 | 1792.3 | |||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | -104.2 | 36.9 | 21.3 | |||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | -153.7 | 214.8 | 327.7 | |||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||||||||
Total Investments | 0 | 44.7 | 50.5 | 103.9 | |||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 593.9 | 598.8 | 873.5 | |||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 580.7 | 417.4 | 701.3 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -100.9 | -201.6 | -1047.7 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 55.4 | 107.5 | 81.5 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | -6.3 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 6.3 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 72.5 | 321.9 | 158.5 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 54.9 | 254.9 | 274 | |||||||||||||||||||||||||
cash-flows.row.inventory | 0 | 37.3 | 69.4 | 82.4 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -54.9 | -254.9 | -191.9 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 35.2 | 252.6 | -5.9 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 96.2 | -103.9 | 536 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -13.5 | -38.1 | -96 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 63.6 | 253.4 | 434.2 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -250 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 53.3 | 45.4 | 352.6 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 118.3 | 12 | 2 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 221.7 | 272.7 | 442.7 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -454.2 | -585.3 | -1214.9 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -39.6 | -91.5 | -89.2 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 157.7 | 289.5 | 889.4 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -336.2 | -387.3 | -414.7 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.2 | -0.1 | -2 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 9 | 9.2 | -245.7 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 177.9 | 168.9 | 159.8 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 168.9 | 159.8 | 405.5 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 123.3 | 123.8 | -271.7 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -13.5 | -38.1 | -96 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 109.8 | 85.7 | -367.7 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 656.9 | 840.7 | 811.2 | |||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 185.5 | 199.7 | 308 | |||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 471.4 | 641 | 503.2 | |||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 22.1 | 107.3 | 129.4 | |||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 548.8 | 624.1 | 761.4 | |||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 734.3 | 823.8 | 1069.4 | |||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 1.2 | 1.1 | 0.6 | |||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 39.9 | 52.4 | 86.1 | |||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -96.3 | -105 | -134 | |||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 22.1 | 107.3 | 129.4 | |||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -96.3 | -105 | -134 | |||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 39.9 | 52.4 | 86.1 | |||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 44.5 | 55.4 | 107.5 | |||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -172.9 | 14.5 | -21.5 | |||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -173.7 | -90.6 | -155.4 | |||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 32.8 | 10.3 | 46.2 | |||||||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | -215.1 | -100.9 | -201.6 |
Pogosto zastavljeno vprašanje
Kaj je Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) skupna sredstva?
Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) skupna sredstva so 1060346384.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.691.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.028.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -0.366.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -0.307.
Kaj je Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -215144077.220.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 593880759.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 548768543.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.